Thrombin alpha biosimilar - Recpharma

Drug Profile

Thrombin alpha biosimilar - Recpharma

Alternative Names: human recombinant thrombin alpha - Recpharma

Latest Information Update: 11 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Recpharma
  • Class Antihaemorrhagics; Blood coagulation factors; Serine endopeptidases
  • Mechanism of Action Thrombin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Haemorrhage

Most Recent Events

  • 20 May 2015 Early research in Haemorrhage in Iran (Topical) before May 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top